Clea Talley

Title: Clea Talley: Innovator in Pharmaceutical Formulations

Introduction

Clea Talley is a notable inventor based in Camarillo, California. She has made significant contributions to the field of pharmaceutical formulations, particularly in the area of therapeutic proteins. Her innovative work has led to the development of a patented process that enhances the stability and efficacy of these important medical products.

Latest Patents

Clea Talley holds a patent for a process for lyophilized pharmaceutical formulations of a therapeutic protein. This invention involves a systematic approach that includes providing a bulk formulation of the therapeutic protein, measuring its concentration, adjusting the fill weight to achieve a fixed dose, and lyophilizing the formulation. The process is particularly beneficial for formulations with low protein concentrations, ranging from 0.05 mg/mL to 20 mg/mL. This patent represents her commitment to improving pharmaceutical delivery systems.

Career Highlights

Clea Talley is currently associated with Amgen Inc., a leading biotechnology company. Her role at Amgen allows her to apply her expertise in developing innovative solutions for complex pharmaceutical challenges. Her work has not only advanced the field but has also contributed to the overall mission of improving patient outcomes through effective therapies.

Conclusion

Clea Talley's contributions to the field of pharmaceutical formulations exemplify her dedication to innovation and excellence. Her patented process for lyophilized therapeutic proteins showcases her ability to address critical needs in the medical industry. Through her work at Amgen Inc., she continues to make a significant impact on the development of effective pharmaceutical products.